neoadjuvant treatments in surgical oncology

Download Report

Transcript neoadjuvant treatments in surgical oncology

2
nd
International Conference
of Surgical Oncology
SOCIETÀ ITALIANA DI CHIRURGIA ONCOLOGICA
Italian Society of Surgical Oncology, ESSO affiliated
PERUGIA | OCTOBER 23 •24 •25 | 2016
NEOADJUVANT
TREATMENTS IN
SURGICAL ONCOLOGY
Honorary President Giuseppe Noya
CONGRESS VENUE HOTEL GIO’
Congress President Annibale Donini
Una vita senza ricerca non è degna di essere vissuta
Platone
PATRONAGES
2
EXECUTIVE BOARD S.I.C.O.
President
Paolo Delrio
Past President
Achille Lucio Gaspari
Next President
Domenico D’Ugo
Secretary - Treasurer
Massimo Dessena
General Secretary
Franco Roviello
Board Members
Davide Cavaliere
Alessandro Gronchi
Daniele Marrelli
Andrea Muratore
Andrea Percivale
Onco Team Coordinator
Carlo Staudacher
Young Coordinator
Raffaele De Luca
CONGRESS BOARD S.I.C.O.
Honorary President
Giuseppe Noya
Chairmen of the Board
Annibale Donini
General Surgery Emergency
University of Perugia
Tel-Fax: 39-075-5786445
e-mail: [email protected]
Scientific Committee
Domenico D’Ugo
Paolo Delrio
Massimo Dessena
Annibale Donini
Achille Lucio Gaspari
Luigina Graziosi
Franco Roviello
3
CHIARMEN/SPEAKERS
4
Luca Aldrighetti (Milano)
Sergio Alfieri (Roma)
Gabriele Anania (Ferrara)
Giulio Angelini (Genova)
Luca Ansaloni (Bergamo)
Giacomo Antonini (Castiglion del Lago - Perugia)
Francesco Ardito (Roma)
Cynthia Aristei (Perugia)
Carlo Aschele (La Spezia)
Nicola Avenia (Terni)
Daniel Azoulay (Francia)
Paolo Baccari (Perugia)
Gian Luca Baiocchi (Brescia)
Gianandrea Baldazzi (Abano Terme)
Gianpaolo Balzano (Milano)
Francesco Basile (Catania)
Massimo Basti (Pescara)
Claudio Belluco (Aviano)
Pietro Paolo Bianchi (Grossetto)
Alberto Biondi (Roma)
Ugo Boggi (Pisa)
Luigi Bonavina (Milano)
Stefano Bonilauri (Reggio Emilia)
Carlo Boselli (Perugia)
Fausto Breccolotto (Perugia)
Vittorio Bresadola (Udine)
Antonio Brescia (Roma)
Riccardo Bussone (Torino)
Giovanni Butturini (Peschiere del Garda - Verona)
Pietro Giorgio Calò (Cagliari)
Michele Camandona (Torino)
Giovanni Capretti (Rozzano)
Corrado Caracò (Napoli)
Paolo Carcoforo (Ferrara)
Riccardo Casadei (Bologna)
Stefano Cascinu (Modena)
Giampaolo Castagnoli (Spoleto)
Davide Cavaliere (Forlì)
Giorgio Cavallesco (Ferrara)
Emanuel Cavazzoni (Perugia)
Maurizio Cesari (Città di Castello - Perugia)
Vittorio Cherchi (Udine)
Federica Cipriani (Milano)
Roberto Cirocchi (Terni)
Coco Claudio (Roma)
Eugenio Cocozza (Varese)
Alessandro Contine (Città di Castello - Perugia)
Giovanni Conzo (Napoli)
Andrea Coratti (Firenze)
Enrichetta Corgna (Perugia)
Piero Covarelli (Perugia)
Francesco Crafa (Napoli)
Lucio Crinò (Perugia)
Miriam Cuatrecasas (Spagna)
Maria Cristina Cucchi (Bologna)
Michele D’Ajello (Terni)
Verena De Angelis (Perugia)
Franco De Cian (Genova)
Maurizio De Giuli (Torino)
Giovanni De Manzoni (Verona)
Antonino De Paoli (Aviano)
Stefano De Pascale (Milano)
Paolo Del Rio (Prato)
Paolo Delrio (Napoli)
CHIARMEN/SPEAKERS
Marcello Deraco (Milano)
Massimo Dessena (Cagliari)
Franco Di Filippo (Roma)
Francesco Di Marzo (Viareggio)
Pier Luigi Di Sebastiano (Chieti)
Domenico D’Ugo (Roma)
Sara Emerenziani (Roma)
Giorgio Ercolani (Bologna)
Alessandra Fabi (Roma)
Massimo Falconi (Milano)
Alessandro Ferrero (Torino)
Marco Fiore (Milano)
Stefano Fiorucci (Perugia)
Massimo Framarini (Forlì)
Uberto Fumagalli (Milano)
Viviana Galimberti (Milano)
Alfredo Garofalo (Roma)
Carlo Garufi (Pesaro)
Gianluca Garulli (Riccione)
Achille Lucio Gaspari (Roma)
Marcello Gasparrini (Roma)
Simone Giacopuzzi (Verona)
Paolo Giovenali (Perugia)
Roberto Girelli (Peschiera)
Felice Giuliante (Roma)
Olivier Glehen (Francia)
Luigina Graziosi (Perugia)
Giovanni Grignani (Torino)
Guido Griseri (Savona)
Mario Guerrieri (Ancona)
Michele Guida (Bari)
Nino Gullà (Messina)
Giovanni B. Ivaldi (Pavia)
Francesco Izzo (Napoli)
Shigeki Kusumura (Milano)
Francesco Leone (Torino)
Alberto Liboni (Ferrara)
Roberto Lo Tesoriere (Torino)
Celestino Pio Lombardi (Roma)
Sara Lonardi (Padova)
Marcello Lucchese (Firenze)
Roberta Lucchini (Terni)
Antonio Macrì (Messina)
Giuseppe Malleo (Verona)
Pierluigi Marini (Roma)
Daniele Marrelli (Siena)
Mario Martinotti (Cremona)
Marco Massani (Treviso)
Davide Melisi (Verona)
Carlo Milandri (Empoli)
Edoardo Minciotti (Branca - Perugia)
Vincenzo Minotti (Perugia)
Simone Mocellin (Padova)
Massimo Monacelli (Perugia)
Paolo Morgagni (Forlì)
Matteo Moro (Milano)
Gianni Mura (Arezzo)
Andrea Muratore (Torino)
Roberto Murgo (San Giovanni Rotondo)
Giuseppe Navarra (Messina)
Donato Nitti (Padova)
Andrea Oddi (Roma)
Elena Orsenigo (Milano)
Diamante Pacchiarini (Perugia)
5
CHIARMEN/SPEAKERS
FRAY,
11TH SEMBER 2015
6
Maria Teresa Paganelli (Perugia)
Raffele Palaia (Napoli)
Giovanni Pallabazzer (Pisa)
Dante Palli (Parma)
Vincenzo Panebianco (Taormina)
Francesco Papadia (Genova)
Amilcare Parisi (Terni)
Enrico Maria Pasqual (Udine)
Daniela Pasquali (Napoli)
Alberto Patriti (Perugia)
Maurizo Pavanello (Asolo)
Riccardo Pellicci (Savona)
Elisabetta Pennacchioli (Milano)
Andrea Percivale (Savona)
Pasquale Perri (Roma)
Roberto Persiani (Roma)
Filippo Pietrantonio (Milano)
Andrea Polistena (Perugia)
Alfredo Pontecorvi (Roma)
Fernando Prete (Bari)
Eugenio Procaccini (Napoli)
Salvatore Pucciarelli (Padova)
Efisio Puxeddu (Perugia)
Vincenzo Quagliuolo (Milano)
Stefano Rausei (Varese)
Andrea Risaliti (Udine)
Manuela Robella (Torino)
Fausto Roila (Terni)
Giovanni Romano (Napoli)
Fabio Rondelli (Perugia)
Riccardo Rosati (Milano)
Carlo Rossi (Padova)
Franco Roviello (Siena)
Antonio Rulli (Perugia)
Alberto Ruol (Padova)
Roberto Salvia (Verona)
Sergio Sandrucci (Torino)
Alessandro Sanguinetti (Terni)
Cinzia Sassaroli (Napoli)
Stefano Scabini (Genova)
Stefano Scaringi (Firenze)
Marco Scatizzi (Prato)
Salvatore Sorrenti (Roma)
Giovanni Sgroi (Treviglio)
Angelo Sidoni (Perugia)
Nicola Silvestris (Bari)
Michele Simone (Bari)
Nicola Solari (Genova)
Antonio Sommariva (Padova)
Mario Taffurelli (Bologna)
Mario Testini (Bari)
Alessandro Testori (Milano)
Guido Alberto Massimo Tiberio (Brescia)
Giovanni Antonio Tommaselli (Roma)
Stefano Turi (Milano)
Paolo Ubiali (Pordenone)
Marco Vaira (Torino)
Vincenzo Valentini (Roma)
Mario Valle (Roma)
Christian Wittekind (Germania)
Alberto Zaniboni (Brescia)
Alessandro Zerbi (Rozzano)
Costantino Zingaretti (Pesaro)
CHAIRMEN/SPEAKERS
FRAY,
11TH SEPER 2015YOUNG SICO SESSION
Francesco Ardito (Roma)
Maria Astorino, (Grosseto)
Claudio Belluco (Aviano-Pordenone)
Maria Bencivenga (Verona)
Pietro Paolo Bianchi (Grosseto)
Davide Cavaliere (Forli)
Coco Claudio (Roma)
Andrea Cossu (Milano)
Lorenzo De Franco (Siena)
Maurizio De Giuli (Torino)
Raffaele De Luca (Bari)
Matteo Donadon (Rozzano-Milano)
Ugo Elmore (Milano)
Giorgio Ercolani (Forli)
Giulia Fiorilli (Siena)
Giampaolo Formisano (Grosseto)
Matteo Frasson (Valencia)
Gaetano Gallo (Catanzaro)
Maria Antonietta Gambacorta (Roma)
Daniela Greto (Firenze)
Francesco Izzo (Napoli)
Maddalena Leongito (Napoli)
Laura Lorenzon (Roma)
Francesco Maione (Napoli)
Luigi Marano (Spoleto)
Mario Marini (Siena)
Daniele Marrelli (Siena)
Alfredo Mellano (Candiolo-Torino)
Riccardo Memeo (Acquaviva delle Fonti - Bari)
Annalisa Milano (Milano)
Marco Milone (Napoli)
Pasquale Misitano (Grosseto)
Armando Orlandi (Roma)
Ugo Pace (Napoli)
Alberto Patriti (Spoleto)
Andrea Percivale (Pietra Ligure)
Karol Polom (Posznan (Pl))
Fernando Prete (Acquaviva delle Fonti - Bari)
Salvatore Pucciarelli (Padova)
Francesca Ratti (Milano)
Stefano Rausei (Varese)
Daniela Rega (Napoli)
Angelo Restivo (Cagliari)
Gianluca Rizzo (Roma)
Giandomenico Roviello (Brescia)
Francesco Ruotolo (Roma)
Andrea Ruzzenente (Verona)
Edoardo Saladino (Messina)
Lucia Salvischiani (Grosseto)
Dario Scala (Napoli)
Michele Simone (Bari)
Vincenzo Simonelli (Lussemburgo)
Jacopo Weindelmayer (Verona)
7
SYNOPTIC TABLE
SUNDAY, OCTOBER 23rd 2016
TRUMPET HALL 1
13.00 PRE-CONGRESS SYMPOSIUM YOUNG SICO
17.30
18.30 INAUGURAL CEREMONY
Palazzo Bernabei - Assisi
MONDAY, OCTOBER 24th 2016
8
TOWN HALL
TRUMPET HALL 1
TRUMPET HALL 2
08.30
10.30
SIEWERT II/III
ADENOCARCINOMA
OF THE ECG:
OPEN PROBLEMS
NEOADJUVANT
THERAPY IN BREAST
CANCER
CHALLENGING SCENARIOS
IN COLORECTAL LIVER
METASTASIS
10.30
12.30
NEOADJUVANT
CHEMOTHERAPY (NAC)
IN GASTRIC CANCER
NEOADJUVANT
THERAPY OF CUTANEOUS
MELANOMA
VIDEO SESSION
LIVER SURGERY
12.30
13.00
AWARDS CEREMONY
LUANA RICCA
13.00
14.30
LUNCHTIME LECTURES
14.30
16.30
GASTRIC CANCER
PERITONEAL
CARCINOMATOSIS:
HOW DO WE TREAT IT?
ERAS IN GASTRONINTESTINAL MEDULLARY THYROID
CANCER
CARCINOMA: UP DATE ON
DIAGNOSTIC AND MULTIDISCIPLINARY TREATMENT
16.30
18.30
MINIINVASIVE SURGERY
IN GASTRIC CANCER’S
TREATMENT
OSNA AND CLINICAL
APPLICATION
IN GASTROINTESTINAL
TUMOURS
PLENARY ROOM - TOWN HALL
18.30 SICO GENERAL ASSEMBLY
19.30
YOUNG SICO COURSE
ON MULTIDISCIPLINARY
EVALUATION
OF GASTROINTESTINAL
CANCER
SYNOPTIC TABLE
TUESDAY, OCTOBER 25th 2016
TOWN HALL
TRUMPET HALL 1
TRUMPET HALL 2
08.30
10.30
RECTAL CANCER:
NEOADJUVANT
NEOADJUVANT
STRATEGIES IN SOFT
TISSUE SARCOMA
AND GIST
NEOADJUVANT THERAPY
IN PANCREATIC
ADENOCARCINOMA
10.30
12.30
PREVENTION OF SURGICAL Y-SICO ACTIVITY
SITE INFECTION
FUTURE PLANS & STUDY
PROPOSAL
12.30
13.00
AWARDS CEREMONY
FONDAZIONE
GUIDO BERLUCCHI
13.00
14.30
LUNCHTIME LECTURES
14.30
16.30
COLON CANCER
PERITONEAL
CARCINOMATOSIS:
CLINICAL EVIDENCES
16.30
18.30
MINIINVASIVE SURGERY IN
THE TREATMENT OF COLON CANCER
VIDEO SESSION
Selected communications: Selected Communications:
UPPER GI
COLORECTAL CANCER
AND PERITONEAL
CARCINOMATOSIS
9
SUNDAY, OCTOBER 23rd 2016
13.00 - 17.30 PRE-CONGRESS SYMPOSIUM YOUNG SICO
TRUMPET 1 HALL
HOTEL GIÒ - PERUGIA
Event Coordinators:
Y-SICO BOARD
R. De Luca, D. Rega, M. Bencivenga, L. De Franco, M. Leongito, A. Mellano
M. Milone, E. Saladino
UPPER GI
Coordinators: M. Bencivenga, L. De Franco, M. Milone
Senior Chairman: M. Simone
Young Chairmen: M. Bencivenga, M. Milone
13.00 Surgical Anatomy
F. Ruotolo
13.15 Ivor Lewis by open approach
J. Weindelmayer
13.25 D2 Gastrectomy by open approach
K. Polom
13.45 Laparoscopic D2 Gastrectomy
A. Cossu
13.55 Gastric Robotic Surgery
L. Marano
14.05 Surgical management of esophageal-jejunal leakage
L. De Franco
Expert Discussant: M. De Giuli, U. Elmore, D. Marrelli
14.15 Debate-take home message
COLORECTAL SESSION
10
Coordinators: R. De Luca, A. Mellano, D. Rega
Senior Chairman: F. Prete
Young Chairmen: R. De Luca, D. Rega
14.30 Surgical Anatomy
F. Ruotolo
14.45 Right Colectomy Open & laparoscopic approach
V. Simonelli
14.55 Left Colectomy Open & laparoscopic approach
G. Gallo
SUNDAY, OCTOBER 23rd 2016
15.05
Splenic flexure cancer: robotic surgical approach
L Salvischiani
15.15 Laparoscopic TME
M. Milone
15.25 Rectal cancer by TA-TME approach
A. Mellano
15.35 Abdominoperineal Amputation & pelvic floor reconstruction
M. Frasson
Expert Discussant: D. Cavaliere, A. Restivo, D. Scala
15.45 Debate-take home message
HEPATIC SESSION
Coordinators: M. Leongito, E. Saladino
Senior Chairman: F. Izzo
Young Chairmen: M. Leongito, E. Saladino
16.00 Surgical Anatomy
F. Ruotolo
16.15 Liver intraoperative ultrasound: role and indication
M. Donadon
16.25 Right Hepatectomy by open approach
F. Ardito
16.35 Right Hepatectomy by laparoscopic approach
F. Ratti
16.45 Left Hepatectomy/ Left Lobectomy by open approach
A. Ruzzenente
16.55 Left hepatectomy/left lobectomy by laparoscopic approach
R. Memeo
17.05 Posterior Hepatic Segmentectomy by robotic approach
A. Patriti
Expert discussant: G. Ercolani, A. Percivale, M. Simone
17.15 Debate-take home message
OPENING CEREMONY
18.30
Palazzo Bernabei - Assisi
11
MONDAY, OCTOBER 24th 2016
PLENARY ROOM
TOWN HALL
8.30 - 10.30
SIEWERT II/III ADENOCARCINOMA OF THE ECG: OPEN PROBLEMS
Chairmen: G. De Manzoni, V. Minotti, A. Zaniboni
8.30
8th AJCC-UICCTNM Classification: nodal Involvement and Choice
of Lymphadenectomy
S. Giacopuzzi
8.45
Siewert II: Type of Resection: Total Gastrectomy or Subtotal Esophagectomy
R. Rosati
9.00
Neoadjuvant Treatment: Chemoradiotherapy? Chemotherapy?
A. Zaniboni
9.15
Molecular biomarkers of response to neoadjuvant treatments
in EGJ adenocarcinoma
D. Melisi
9.30Stage IV without peritoneal carcinomatosis: is there space
for Conversion Surgery?
G. Pallabazzer
9.45 - 10.05
Selected Communications
CROSS REGIMEN FOR ESOPHAGEAL CANCER: SINGLE CENTER EXPERIENCE
Puccetti F.*[1], De Pascale S.[1], Garassino I.[1], Cavina R.[1], Tozzi A.[1], Fumagalli U.[1],
Rosati R.[2]
[1]
IRCCS Humanitas Research Hospital ~ Rozzano (MI) ~ Italy, [2]IRCCS San Raffaele
Hospital ~ Milano ~ Italy
ROBOTIC ESOPHAGECTOMY: OUR EXPERIENCE AND PRELIMINARY RESULTS
Bartolini I.*, Vegni A., Annecchiarico M., Bencini L., Moraldi L., Di Marino M.,
Pesi B., Coratti A. - AOU Careggi ~ Firenze ~ Italy
10.05Discussion
Discussants: L. Bonavina, M. Camandona, A. Ruol
10.30 - 12.30
12
NEOADJUVANT CHEMOTHERAPY (NAC) IN GASTRIC CANCER
Chairmen: E. Orsenigo, F. Roviello
10.30 Evidences and controversies from Literature
M. De Giuli
10.45 NAC in gastric cancer: Who may benefit
S. Rausei
11.00 NAC in gastric cancer: preoperative or perioperative?
P. Morgagni
11.15 Different CHT protocols in NAC for GC
C. Milandri
MONDAY, OCTOBER 24th 2016
11.30
Surgical implications after NAC
D. Marrelli
11.45 - 12.05
Selected Communications
ROLE OF EXETENDED LYMPHADENECTOMY IN GASTRIC CANCER SURGERY:
A RETROSPECTIVE SINGLE CENTRE EXPERIENCE
Lomonaco R.[1], De Luca R.[1], Caliandro C.[1], Ruggieri E.[1], Nannavecchia A.[2], Rucci A.[1],
Ammendola M.*[3], Simone M.[1]
[1]
National Cancer Research Centre “G.Paolo II” Istituto Tumori ~ BARI ~ Italy,
[2]
Puglia Cancer Registry ~ Bari ~ Italy, [3]Clinical Surgery Unit. University
of “Magna Grecia” ~ Catanzaro ~ Italy
MIR375 EXPRESSION AND DIFFUSE-TYPE GASTRIC CANCERS
Avantifiori R.*[1], Lorenzon L.[1], Mercantini P.[1], Cippitelli C.[2], Uccini S.[2], French D.[2],
Torrisi M.R.[2], Canu V.[3], Blandino G.[3], Cavallini M.[1]
[1]
Surgical and Medical Department of Traslational Medicine, Faculty of Medicine and
Psychology, University of Rome “La Sapienza”, Sant’Andrea Hospital of Rome, Italy ~
Rome ~ Italy, [2]Department of Clinical and Molecular Medicine, Faculty of Medicine and
Psychology, University of Rome “La Sapienza”, Sant’Andrea Hospital of Rome,
Italy ~ Rome ~ Italy, [3]Translational Oncogenomic Unit, Italian National Cancer Institute
Regina Elena, Rome, Italy ~ Rome ~ Italy
12.05Discussion
Discussants: R. Palaia, V. Panebianco, R. Persiani
12.30 - 13.00
AWARDS CEREMONY
LUANA RICCA
LUNCHTIME LECTURES:
13.00 Surgery in liver colorectal metastases
D. Azoulay
13.45 Satellite Session
Electrochemotherapy: Meet the expert
F. Izzo
14.30 - 16.30 GASTRIC CANCER PERITONEAL CARCINOMATOSIS: HOW DO WE TREAT IT?
Chairmen: V. De Angelis, A. Garofalo
14.30 Adjuvant HIPEC in Locally AGC
L. Ansaloni
14.45 GASTRICHIP: preliminary results
O. Glehen
15.15 Therapeutic HIPEC
F. Roviello
13
MONDAY, OCTOBER 24th 2016
15.30
Extensive Lavage
L. Graziosi
15.45 - 16.00
Selected Communications
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) AND NEOADJUVANT
CHEMOTHERAPY AS PROPHYLAXIS OF PERITONEAL CARCINOSIS FROM ADVANCED
GASTRIC CANCER-EFFECTS ON OVERALL AND DISEASE FREE SURVIVAL
Coccolini F., Celotti A., Ceresoli M., Montori G.*, Fugazzola P., Ansaloni L.
Ospedale Papa Giovanni 23 ~ Bergamo ~ Italy
16.00Discussion
Discussants: A. Macrì, S. Scaringi, M. Valle
16.30 - 18.30
14
MINIINVASIVE SURGERY IN GASTRIC CANCER TREATMENT
Chairmen: D. D’Ugo, G. Tiberio
16.30 Laparoscopic total gastrectomy surgical technique
A. Biondi
16.50 Laparoscopic subtotal gastrectomy surgical technique
G. Sgroi
17.10 Laparoscopic D2 Lymphadenectomy in gastric cancer surgery
E. Cocozza
17.30 Robotic approach in gastric cancer surgery
A. Coratti
17.50 - 18.10
Selected Communications
LYMPH NODE DISSECTION GUIDED BY INDOCYANINE GREEN FLUORESCENCE IMAGING
DURING ROBOTIC SURGERY FOR GASTRIC CANCER
Staderini F.*[1], Foppa C.[1], Indennitate G.[3], Badii B.[1], Novelli L.[2], Paoli B.[3], Ortolani M.[3],
Skalamera I.[1], Qirici E.[1], Perigli G.[1], Cianchi F.[1]
[1]
Center of Oncological Minimally Invasive Surgery (COMIS), Department of Surgery and
Translational Medicine, University of Florence, Italy ~ Florence ~ Italy, [2]Department of
Experimental and Clinical Medicine, University of Florence, Florence, Italy ~ Florence ~
Italy, [3]IFCA ~ Florence ~ Italy
TOTALLY MINIMALLY INVASIVE VS HYBRID ESOPHAGECTOMY FOR CANCER: A
COMPARATIVE PROSPECTIVE STUDY ON SAFETY AND EFFICACY.
Melis A.*, Parise P., Incarbone N., Adamenko O., Mazza M., Giannone F., Cossu A., Rosati R.
San Raffaele Hospital ~ Milano ~ Italy
18.10Discussion
Discussants: C. Boselli, M. Cesari, M. Scatizzi
18.30 - 19.30
SICO GENERAL ASSEMBLY
MONDAY, OCTOBER 24th 2016
TRUMPET
HALL 1
8.30 - 10.30
NEOADJUVANT THERAPY IN BREAST CANCER
Chairmen: P. Carcoforo, A. Fabi, R. Murgo
8.30
Italian Survey
M. Dessena
8.45
Dedicated Diagnostic Therapeutic Care Pathways:
M. Taffurelli
9.00
The future of therapy for HER2+ patients
A. Fabi
9.15
Axillary-Conserving Surgery:
V. Galimberti
9.30
Mastectomy after NAC
M.C. Cucchi
9.45
Radiotherapy
G.B. Ivaldi
10.00 - 10.20
Selected Communications
FEASIBILITY OF LYMPHOSCINTIGRAPHY FOR SENTINEL NODE IDENTIFICATION
AFTER NEO-ADJUVANT THERAPY
Corso G.*[1], Vicina E.[1], Baio S.M.[2], Gilardi L.[2], Maisonneuve P.[3], Grana C.M.[2], Galimberti V.[1]
[1]
Division of Senology, European Institute of Oncology ~ Milan ~ Italy, [2]Division of Nuclear
Medicine, European Institute of Oncology ~ Milan ~ Italy, [3]Division of Epidemiology and
Biostatistics, European Institute of Oncology ~ Milan ~ Italy
THE ROLE OF NEOADJUVANT CHEMOTERAPY IN CHOOSING THE TYPE OF SURGERY
IN BREAST CANCER HER2+ AND TRIPLE NEGATIVE.
Calderoni S.*[1], Brulatti M.[1], Cuoghi M.[1], Galluzzo V.[1], Ferrarini R.[1], Zanarini D.[1],
Cucchi M.C.[2]
[1]
Breast Unit Ospedale Bellaria ~ BOLOGNA ~ Italy, [2]Direttore Breast Unit Ospedale
Bellaria ~ BOLOGNA ~ Italy
10.20Discussion
Discussants: R. Bussone, D. Palli, P. Perri, E. Procaccini
10.30 - 12.30
NEOADJUVANT THERAPY OF CUTANEOUS MELANOMA
Chairmen: C. Caracò, A. Testori
10.30 Target and immunotherapy in advanced melanoma treatment
E. Corgna
10.45 Neoadjuvant target therapy in advanced melanoma treatment C. Caracò
15
MONDAY, OCTOBER 24th 2016
11.00
Neoadjuvant immunotherapy with check point inhibitors
in advanced melanoma
S. Mocellin
11.15 Isolated limbs perfusion: could it be considered as a neoadjuvant therapy?
Our experience and results.
F. Papadia
11.30 Surgery after stage II-III and IV neoadjuvant therapies
A. Testori
11.45Discussion
Discussants: P. Covarelli, M. Guida, C. Rossi, N. Solari, A. Sommariva
LUNCHTIME
14.30 - 16.30
16
ERAS IN GASTRONINTESTINAL CANCER
Chairmen: A. Brescia, U. Fumagalli
14.30 ERAS in Gastric Cancer
S. De Pascale
14.45 Eras in esophageal cancer
R. Rosati
15.00 Eras in colorectal cancer
M. Gasparrini
15.15 Anesthesiologist’s perspectives
S. Turi
15.30 - 15.50
Selected communications
IMPACT OF EXPERIENCE IN ENHANCED RECOVERY AFTER SURGERY (ERAS)
FOR ESOPHAGEAL SURGERY
Weindelmayer J.*[1], Giacopuzzi S.[1], Zanoni A.[2], Gobbi L.[1], De Pasqual C.A.[1], De Manzoni G. [1]
[1]
Upper GI surgery AOUI B.go Trento ~ Verona ~ Italy, [2]Chirurgia generale ~ Rovereto ~ Italy
ENHANCED RECOVERY AFTER SURGERY (ERAS) PROTOCOL IN GASTRIC SURGERY
FOR CANCER: REVIEW OF A SINGLE INSTITUTION EXPERIENCE.
Cossu A.*, Parise P., Melis A., Giannone F., Mazza M., Adamenko O., Elmore U., Rosati R.
Division of Gastrointestinal Surgery, San Raffaele Hospital IRCCS ~ Milano ~ Vanuatu
15.50Discussion
Discussants: A. Contine, S. Emerenziani, M.T. Paganelli
16.30 - 18.30
OSNA AND CLINICAL APPLICATION IN GASTROINTESTINAL TUMOURS
Chairmen: S. Fiorucci, P. Giovenali, A. Rulli, A. Sidoni
16.30 Molecular Staging in Colon Cancer
M. Cuatrecasas
17.15 Sentinel node in colorectal cancer
F. Crafa
MONDAY, OCTOBER 24th 2016
17.45
The use of OSNA Nomogram in the decision treatment algorithm of breast cancer
patients with positive SLN
F. Di Filippo
18.15 - 18.25
Selected communication
THE USE OF ONE-STEP NUCLEIC ACID AMPLIFICATION (OSNA) FOR INTRAOPERATIVE
DETECTION OF LYMPH NODE METASTASIS IN BREAST CANCER PATIENTS. PRELIMINARY
DATA FROM A RETROSPECTIVE STUDY OF 56 CASES.
Salaris C.*, Sanna S., Medas F., Gordini L., Podda F., Tatti A., Calò P.G.
Policlinico Universitario ~ Monserrato (CA) ~ Italy
18.25Discussion
17
MONDAY, OCTOBER 24th 2016
TRUMPET
HALL 2
8.30 - 10.30
CHALLENGING SCENARIOS IN COLORECTAL LIVER METASTASIS
Chairmen: C. Garufi, R. Pellicci
8.30
CCR with liver only metastasis: what is the optimal neoadjuvant regimen?
C. Aschele
8.45 How to increase resectability of colorectal liver metastasis?
A. Ferrero
9.00
What is the impact of preoperative chemotherapy
on resectability ?
F. Giuliante
9.15
How to manage the “Vanishing Lesions”
L. Aldrighetti
9.30
Impact of HAI on chemotherapy regimen in the treatment of colorectal liver
metastasis
M. Massani
9.45 - 10.05
Selected Communications
ROLE OF R1 LIVER RESECTIONS FOR COLORECTAL METASTASES IN THE ERA
OF MODERN CHEMOTHERAPY
Ferrucci M.*, Ardito F., Coppola A., Panettieri E., Vellone M., Giuliante F.
Università Cattolica del Sacro Cuore - Policlinico “A. Gemelli” ~ Roma ~ Italy
CEACAM5 MRNA IN BLOOD AS PROGNOSTIC BIOMARKER OF EARLY RECURRENCE IN
LIVER METASTATIC COLORECTAL CANCER PATIENTS
Panettieri E.*[1], Ardito F.[1], Giuliante F.[1], Mele C.[1], Vellone M.[1], Pocino K.[2], Autilio C.[2],
Paolillo C.[2], Capoluongo E.[2]
[1]
Catholic University, Hepatobiliary Surgery Unit ~ Rome ~ Italy, [2]Catholic University,
Laboratory of Clinical Molecular and Personalized Diagnostics ~ Rome ~ Italy
10.05Discussion
Discussants: G. Ercolani, G. Griseri, F. Leone A. Percivale
18
10.30 - 12.30
VIDEO SESSION - LIVER SURGERY
Chairmen: D. Azoulay, A. Risaliti
10.30 Complex lap liver resections for colorectal mets: pushing the limits
F. Cipriani
10.50 Laparoscopic two-stage hepatectomy for multiple bilateral colorectal metastases
R. Lo Tesoriere
11.10 Two stage hepatectomy with occlusion of left portal vein and of right anterior
portal vein
F. Ardito
MONDAY, OCTOBER 24th 2016
11.30
Major hepatectomy by means of linear stapler Alpps
V. Cherchi
11.50 Hepatic resection of the 8th segment for cholangiocarcinoma
G. Angelini
Discussants: E. Cavazzoni, R. Cirocchi , A. Patriti
LUNCHTIME
14.30 - 16.30 MEDULLARY THYROID CARCINOMA:
UPDATE ON DIAGNOSTIC AND MULTIDISCIPLINARY TREATMENT
Chairmen: A. Pontecorvi, M. Testini
14.30 Update on diagnosis of medullary thyroid carcinoma
P. Del Rio
14.45 Genetics of medullary thyroid carcinoma
D. Pasquali
15.00 Medullary thyroid carcinoma: Prophylactic treatment: When and how
C.P. Lombardi
15.15 Surgical treatment of medullary thyroid carcinoma: What Lymphectomy?
N. Avenia
15.30 The role of new drugs in medical treatment of medullary thyroid carcinoma
E. Puxeddu
15.45 - 16.05
Selected Communications
CENTRAL NECK DISSECTION IN CLINICALLY NODE-NEGATIVE PATIENTS WITH
DIFFERENTIATED THYROID CANCER: WHERE ARE WE NOW? A CRITICAL ANALYSIS
OF OUR EXPERIENCE
Podda F.*, Gordini L., Medas F., Tatti A., Erdas E., Pisano G., Calò P.G.
Department of Surgical Sciences - University of Cagliari ~ Cagliari ~ Italy
UNDETERMINED NODULES (THY3) AND THYROID CARCINOMA: A CRITICAL
ANALYSIS OF OUR EXPERIENCE
Gordini L.*, Medas F., Podda F., Salaris C., Pisano G., Erdas E., Calò P.G.
Department of Surgical Sciences - University of Cagliari ~ Cagliari ~ Italy
16.05Discussion
Discussants: P.G. Calò, G. Conzo, M. D’Ajello, R. Lucchini, M. Monacelli, A. Polistena,
A. Sanguinetti, S. Sorrenti
16.30 - 18.30
16.30
16.40
YOUNG SICO COURSE ON MULTIDISCIPLINARY EVALUATION
OF GASTROINTESTINAL CANCER
Lecture: Organization and relevance of the multidisciplinary
team for the evaluation and treatment of gastrointestinal cancer.
D. Greto
Comment of
A. Milano
19
MONDAY, OCTOBER 24th 2016
Updates on Locally Advanced Gastric Cancer
Senior Chairman: D. Marrelli
Young Chairmen: M. Bencivenga, A. Mellano
Opinion of:
16.45 Endoscopist: Endoscopic Ultrasound and Staging Laparoscopy
G. Fiorilli
16.50 Oncologist: Neoadjuvant Chemo-Therapy
G. Roviello
16.55 Surgeon: Role of Surgery
L. De Franco
Expert Discussant: M. De Giuli, M. Marini, S. Rausei
Updates on Stage IV Colon Cancer
Senior Chairman: P.P. Bianchi
Young Chairmen: M. Milone, D. Rega
Opinion of:
17.20 Oncologist: Neoadjuvant Chemo-Therapy
M. Astorino
17.30 Endoscopist: Treatment of stenotic cases
F. Maione
17.40 Surgeon: Details on Resection of Primary Tumor
G. Formisano
17.45 Surgeon: Timing of Colorectal Cancer Liver Metastases’ Resection
P. Misitano
Expert Discussant: C. Belluco, D. Cavaliere, U. Pace
Updates on Stage IV Rectal Cancer
20
Senior Chairman: C. Coco
Young Chairmen: R. De Luca, E. Saladino
Opinion of:
18.00 Oncologist: Induction Chemo-Therapy
A. Orlandi
18.10 Radiotherapist: Standard of Neoadjuvant Radio-Therapy
A. Gambacorta
18.20 Surgeon: Treatment of Primary Tumor and the Role of Organ Preservation
G. Rizzo
18.30 Surgeon: Resectability of Hepatic Metastases
F. Ardito
Expert Discussant: D. Cavaliere, S. Pucciarelli, D. Scala
TUESDAY, OCTOBER 25th 2016
PLENARY ROOM
TOWN HALL
8.30 - 10.30
RECTAL CANCER: NEOADJUVANT
Chairmen: P. Marini, D. Nitti, V. Valentini
8.30
Is neoadjuvant therapy always required for clinical stages II-III rectal cancer?
P. Delrio
8.45
Management of asymptomatic stage IV rectal cancer
S. Cascinu
9.00
Rectum sparing approaches after neoadjuvant therapy
C. Coco
9.15
Transanal TME after neoadjuvant therapy
A. Muratore
9.30
Research Study
S. Pucciarelli
9.45 - 10.05
Selected Communications
PROGNOSTIC VALUE OF THE NUMBER OF RETRIEVED LYMPH NODES IN NODE NEGATIVE
PATIENTS WHO UNDERWENT NEOADJUVANT CHEMORADIATION THERAPY OR RADIATION
THERAPY ALONE. RESULTS OF THE ITALIAN COLORECTAL ONCOTEAM MULTICENTRE STUDY.
M. Degiuli for the Italian Colorectal Oncoteam
FACTORS INFLUENCING LYMPH NODE YIELD IN COLORECTAL CANCER
Luperto M.*, Gasparini G., Orsenigo E., Carlucci M.
San Raffaele Hospital ~ Milan ~ Italy
10.05Discussion
Discussants: C. Aristei, C. Belluco, A. De Paoli,, S. Lonardi, F. Prete, G. Romano
11.00 - 12.30
SYMPOSIUM PREVENTION OF SURGICAL SITE INFECTION
Chairmen: M G. Cavallesco, M. Lucchese, D. Pacchiarini
11.00 Healthcare Associated Infections (HCAI): incidence and economic impact
M. Moro
11.40 Infection Prevention in the neoplastic patient
F. Di Marzo
12.00 Bundle of care: evalutation, effectiveness and clinical evidence
G.A. Tommaselli
(Relazione non accreditata ECM)
12.20 Conclusions and key messagges
12.30 - 13.00
AWARDS CEREMONY
FONDAZIONE GUIDO BERLUCCHI
21
TUESDAY, OCTOBER 25th 2016
LUNCHTIME LECTURES:
13.00 Principles of Tnm Staging After Neo-Adjuvant Treatments
C. Wittekind
13.30 Colorectal Carcinomatosis: Cytoreductive Surgery and HIPEC as a standard
of treatment
O. Glehen
14.30 - 16.30 COLON CANCER PERITONEAL CARCINOMATOSIS:
CLINICAL EVIDENCES
22
Chairmen: L. Crinò, O. Glehen, M. Vaira
14.30 Adjuvant HIPEC in Locally ACC
M. Deraco
14.45 Therapeutic HIPEC
M. Robella Surgical point of view
F. Pietrantonio Oncologist’s point of view
15.15 Hipec in rectal cancer
C. Sassaroli
15.30 Learning Curve and Surgical Performance of Cytoreductive Surgery and HIPEC
S. Kusamura
15.45 - 16.05
Selected Communications
EVALUATION OF THE SHORT-TERM OUTCOME OF CYTOREDUCTIVE SURGERY PLUS
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY USED IN THE TREATMENT
OF COLO-RECTAL CARCINOMATOSIS: A MULTI-INSTITUTIONAL STUDY
Macrì A.*[1], Saladino E.[2]
[1]
Department of Human Pathology ~ Messina ~ Italy, [2]Casa di cura Cappellani-Giomi ~
Messina ~ Italy
Antonio Macrì1, Vincenzo Arcoraci2, Claudia Giardina2, Valerio Belgrano3, Marina Caldana4,
Tommaso Cioppa5, Franco De Cian3, Giovanni De Manzoni4, Michele De Simone6,
Angelo Di Giorgio7, Francesca Muffatti8, Elena Orsenigo8, Manuela Robella6,
Franco Roviello5, Paolo Sammartino7, Marco Vaira6, Saladino Edoardo9
Affiliation and address of each author: Antonio Macrì: 1Department of Human Pathology,
University of Messina, Italy; Vincenzo Arcoraci, Claudia Giardina: 2Department of Clinical and
Experimental Medicine, University of Messina, Italy; Franco De Cian, Valerio Belgrano: 3Department of Surgery, University of Genoa, Italy; Giovanni De Manzoni, Marina Caldana: 41st
Department of General Surgery, University of Verona, Italy; Franco Roviello,
Tommaso Cioppa: 5Department of Medicine, Surgery and Neuroscience, University of Siena,
Italy; Michele De Simone, Marco Vaira, Manuela Robella: 6Department of Surgical Oncology,
Candiolo Cancer Insitute, Italy; Angelo Di Giorgio, Paolo Sammartino: 7Department of Surgery
“Pietro Valdoni”, University “Sapienza” of Rome, Italy; Elena Orsenigo,
Francesca Muffatti: 8Department of Surgery, San Raffaele Scientific Institute, Milan, Italy;
Edoardo Saladino: 9Casa di Cura Cappellani-GIOMI, Messina, Italy.
TUESDAY, OCTOBER 25th 2016
OVERALL AND DISEASE-FREE SURVIVAL IN PATIENTS TREATED WITH CRS PLUS HIPEC
FOR PERITONEAL CARCINOMATOSIS FROM COLORECTAL AND APPENDICEAL CANCER:
AN UPDATE OF OUR EXPERIENCE.
Fugazzola P.*, Montori G., Coccolini F., Ceresoli M., Ansaloni L.
Ospedale Papa Giovanni 23 ~ Bergamo ~ Italy
16.05Discussion
Discussants: D. Cavaliere, M. Framarini, E.M. Pasqual
16.30 - 18.30 MINIINVASIVE SURGERY IN THE TREATMENT OF COLON CANCER
Chairmen: G. Anania, F. Basile, M. Basti
16.30TATME
R. Persiani
16.45 Mini-invasive surgical approach in left colon cancer
G. Baldazzi
17.00 Robotic approach: evidence from literature
P.P. Bianchi
17.15 Transanal Endoscopic Microsurgery
M. Guerrieri
17.30 Technological Innovations in right colon cancer surgical approach
G. Navarra
17.45 Transverse colectomy: mini-invasive surgical approach
M. Pavanello
18.00 - 18.20
Selected Communications
THE NEW VIEW OF SURGICAL ONCOLOGY: LAPAROSCOPIC 3D TECHNOLOGY USE
IN COLON CANCER
Zuccaro M.*, Valdegamberi A., Portale G., Fiscon V.
Hospital of Cittadella ~ Cittadella, Padua ~ Italy
ROBOTIC TOTAL MESORECTAL EXCISION: 3-YEAR ONCOLOGICAL OUTCOMES AND SUBGROUP ANALYSIS OF PATIENTS SUBMITTED TO NEOADJUVANT CHEMORADIOTHERAPY
Formisano G.*[1], Giuliani G.[1], Misitano P.[1], Coratti F.[1], De Luca M.[1], Krizzuk D.[1],
Petz W.[2], Bianchi P.P.[1]
[1]
MISERICORDIA HOSPITAL ~ Grosseto ~ Italy, [2]European Institute of Oncology
~ Milan ~ Italy
18.20Discussion
Discussants: G. Antonini, F. Breccolotto, N. Gullà, F. Rondelli
23
TUESDAY, OCTOBER 25th 2016
TRUMPET
HALL 1
8.30 - 10.30
NEOADJUVANT STRATEGIES IN SOFT TISSUE SARCOMA AND GIST
Chairmen: V. Quagliuolo, F. Roila
8.30
Is there any standard approach to neoadjuvant chemotherapy in STS?
G. Grignani
8.45
Decision-making and management of preoperative treatments
for rare tumors within a national collaborative network
M. Fiore
9.00
Neoadjuvant radiation therapy in STS: when it is needed, when it is not
A. De Paoli
9.15
Neoadjuvant TKIs in GIST: evolving indications
D. Cavaliere
9.30 - 9.50
Selected Communications
ADHERENCE TO GUIDELINES AND QUALITY OF TREATMENT OF RETROPERITONEAL
SARCOMAS: A RETROSPECTIVE REGIONAL ANALYSIS IN ITALY
Ponzetti A.[2], Gianotti C.[1], Mistrangelo M.[2], Siatis D.[3], Giovanni G.[4], Di Cuonzo D.[5],
Ciccone G.[5], Sandrucci S.*[1]
[1]
Visceral Sarcoma Unit, City of Health and Science University Hospital ~ Torino ~ Italy, [2]
Oncology Department, City of Health and Science University Hospital ~ Torino ~ Italy, [3]
Division of Surgical Oncology, Candiolo Cancer Institute-FPO- IRCCS, Candiolo ~ Torino
~ Italy, [4]Division of Medical Oncology, Candiolo Cancer Institute-FPO- IRCCS, Candiolo ~
Torino ~ Italy, [5]Cancer Epidemiology Unit, CPO Piemonte ~ Torino ~ Italy
ISOLATED LIMB PERFUSION FOR THE MANAGEMENT LIMB THREATENING SOFT TISSUE
SARCOMAS: THE ROLE OF HISTOLOGICAL TYPE ON CLINICAL OUTCOMES
Rastrelli M.*, Tropea S., Mocellin S., Rossi C.R.
IOV ~ Padova ~ Italy
9.50Discussion
Discussants: F. De Cian, E. Pennacchioli, A. Oddi, S. Sandrucci
10. 30 - 12.30
24
YOUNG SICO ACTIVITY - FUTURE PLANS & STUDY PROPOSAL
President: D. Marrelli
Chairmen: R. De Luca, M. Bencivenga
10.30 One Year Y-S.I.C.O. Activity
D. Rega
10.35 Y-S.I.C.O.&Eysac: A Strong Partnership and New Perspectives
L. Marano, L. Lorenzon, R. Memeo, K. Polom
10.40 Y-S.I.C.O. Future Perspectives: Training, Fellowship, Courses
A. Mellano
TUESDAY, OCTOBER 25th 2016
10.55
National Audit On Rectal Cancer Patients with Complete Response
After Neo-Adjuvant Therapy E An Investigation On Behalf
Of The Young Italian Society Of Surgical Oncology (Y-S.I.C.O.)
L. Lorenzon - R. De Luca
11.05 - 12.30
STUDY PROPOSAL BY YOUNG SICO MEMBER
LUNCHTIME
14.30 - 16.30
SELECTED COMMUNICATIONS: UPPER GI
Chairmen: A. Liboni, C. Zingaretti
14.30 THE BILE ACID RECEPTOR GPBAR1 (TGR5) IS EXPRESSED IN HUMAN GASTRIC
CANCERS AND PROMOTES EPITHELIAL-MESENCHYMAL TRANSITION IN GASTRIC
CANCER CELL LINES
Graziosi L.*[1], Marino E.[1], Carino A.[2], Cipriani S.[2], Donini A.[1], Fiorucci S.[2]
[1]
General and Emergency Surgery, Santa Maria della Misericordia Hospital of
Perugia ~ Perugia ~ Italy, [2]Dipartimento di Scienze Chirurgiche e Biomediche,
Università degli Studi di Perugia ~ Perugia ~ Italy
14.40 SEREUM C-REACTIVE PROTEIN AND GASTRIC CANCER: COULD IT BE A PROGNOSTIC MARKER?
Graziosi L., Marino E.*, Maria Cristina V., Donini A.
general and Emergency Surgery, Santa Maria della Misericordia Hospital of Perugia ~ Perugia ~ Italy
14.50 PARENCHYMAL-SPARING HEPATECTOMIES (PSH) FOR BILOBAR COLORECTAL
LIVER METASTASES ARE ASSOCIATED WITH A LOWER MORBIDITY AND SIMILAR
ONCOLOGICAL RESULTS: A PROPENSITY SCORE MATCHING ANALYSIS
Memeo R.*[1], French Surgical Association (.F.D.C.[2]
[1]
Ospedale “F. Miulli” ~ Acquaviva delle Fonti ~ Italy, [2]French Surgical Association (Association Française de Chirurgie) ~ France ~ France
15.00 PROGNOSTIC FACTORS AFTER CURATIVE RESECTIONS FOR GASTRIC CANCER:
RESULTS OF A SERIES OF 534 PATIENTS
Silvestri S.*[1], Deiro G.[2], Amisano M.[1], Cassine D.[2], Fop F.[3], Fronda G.[4], Satolli
M.A.[5], Franchello A.[2]
[1]
Division of Surgery - Santo Spirito Hospital ~ Casale Monferrato (AL) ~ Italy, [2]
Department of Surgery - AOU Città della Salute e della Scienza ~ Torino ~ Italy,
[3]
Department of Kidney Transplantation - AOU Città della Salute e della Scienza
~ Torino ~ Italy, [4]Humanitas Gradenigo Hospital ~ Torino ~ Italy, [5]Department
of Oncology - AOU Città della Salute e della Scienza ~ Torino ~ Italy
15.10 DOWNSTAGING OF LOCALLY ADVANCED PANCREATIC CANCER AFTER MULTIMODAL TREATMENT
Girelli Roberto*, Frigerio Isabella*, Giardino Alessandro* Regi Paolo*, Scopelliti
Filippo*, Pederzoli Paolo*, Bassi Claudio**, Girelli R.*
Casa Di Cura Pederzoli ~ Peschiera Del Garda - Verona ~ Italy
25
TUESDAY, OCTOBER 25th 2016
15.20 A RANDOMIZED PHASE II TRIAL ON NEOADJUVANT CHEMOTHERAPY IN RESECT-
ABLE PANCREATIC ADENOCARCINOMA
Balzano G.*[1], Zanon S.[1], Castoldi R.[1], Aleotti F.[1], Zerbi A.[2], Falconi M.[1], Andreasi V.[1], Gianni L.[1], Nicoletti R.[1], Reni M.[1]
[1]
San Raffele Scientific Institute ~ Milan ~ Italy, [2]Ist. Clinico Humanitas ~ Rozzano ~ Italy
15.30 PLASTICS AND BIDUTTOENTEROANASTOMOSIS FOR KLATSKIN BISMUTH IIIA
TUMOR
Kazemi Nava A.*, D’’Angelo F., De Siena M., Antolino L., Sirimarco D., Aurello P.,
Bersigotti L., Mariano G., Giulitti D., Ramacciato G.
La Sapienza Facoltà di Medicina e Psicologia ~ Rome ~ Italy
15.40 SORAFENIB AS NEOADJUVANT THERAPY FOR ADVANCED HEPATOCELLULAR
CARCINOMA WITH VASCULAR INVASION: LUCKY CHANCE OR EFFECTIVENESS?
Ceriotti M.*[1], Percivale A.[2], Cipriani F.[3], Bruzzone L.[4], Griseri G.[5],
Aldrighetti L.A.[3], Pellicci R.[2]
[1]
Università di Genova ~ Genova ~ Italy, [2]Dipartimento chirurgie, Ospedale
Santa Corona ~ Pietra Ligure (SV) ~ Italy, [3]Ospedale Vita Salute San Raffaele ~
Milano ~ Italy, [4]Gastroenterologia ospedale Santa Corona ~ Pietra Ligure (SV)
~ Italy, [5]Dipartimento chirurgie, Ospedale Santa Corona Ospedale San Paolo ~
Savona ~ Italy
15.50Discussion
Discussants: V. Bresadola , P. Castagnoli, E. Minciotti, G. Mura, M. Simone
26
TUESDAY, OCTOBER 25th 2016
TRUMPET
HALL 2
8.30 - 10.30
NEOADJUVANT THERAPY IN PANCREATIC ADENOCARCINOMA
Chairmen: G. Balzano, E. Corgna
8.30
Clinical cases: surgery first or neoadjuvant treatment?
Clinical Case 1 G. Capretti
Clinical Case 2 G.L. Baiocchi
9.00
Role of neoadjuvant treatment in resectable and borderline pancreatic cancer:
evidences and guidelines
M. Falconi
9.15
Which neoadjuvant treatment in pancreatic cancer?
The oncologist’s doubts
N. Silvestris
9.30
Criteria to select patients for surgery after neoadjuvant treatment
R. Casadei
9.40
Do we do the same? Present practice and results of surgery after neoadjuvant
treatment in two high-volume centers
R. Salvia, U. Boggi
Discussants: S. Alfieri, G Malleo
10.25 ABSTRACT SESSION
Chairmen: S. Alfieri, R. Girelli
Selected communications
IMMUNOLOGICAL PROFILE OF SYSTEMIC EFFECTS AFTER RADIOFREQUENCY ABLATION
OF LOCALLY ADVANCED PANCREATIC CANCER: STUDY DESIGN AND PRELIMINARY
RESULTS
Giardino A.*[1], Girelli R.[1], Frigerio I.[1], Regi P.[1], Scopelliti F.[1], Butturini G.[1], Pederzoli
P.[1], Bassi C.[2]
[1]
Casa di Cura Pederzoli - Chirurgia Pancreatica ~ Peschiera del Garda (VR) ~ Italy,
[2]
Pancreas Institute ~ Verona ~ Italy
PREDICTIVE ROLE OF INTRAOPERATIVE FROZEN SECTION IN DETECTION OF
PANCREATIC FISTULA AFTER PANCREATICODUODENECTOMY: PRELIMINARY RESULTS.
Silvestri S.*[4], Deiro G.[1], Amisano M.[4], Cassine D.[1], Chiusa L.[2], Fronda G.[3],
Franchello A.[1], Molinaro L.[2]
[1]
Department of Surgery - AOU Città della Salute e della Scienza ~ Torino ~ Italy, [2]
Department of Pathology - AOU Città della Salute e della Scienza ~ Torino ~ Italy, [3]
Humanitas Gradenigo Hospital ~ Torino ~ Italy, [4]Division of Surgery - Santo Spirito
Hospital ~ Casale Monferrato (AL) ~ Italy
27
TUESDAY, OCTOBER 25th 2016
11.00 - 12.30
VIDEO SESSION
Chairmen: P. Baccari, A. Zerbi
ORIGINAL TECHNIQUE OF WIRSUNG-PANCREATICOGASTRIC ANASTOMOSIS AFTER
PANCREATODUODENECTOMY: LOW COMPLICATION RATE IN A SINGLE CENTER
EXPERIENCE IN 100 PATIENTS
Bizzoca C.*, Lippolis A.S., Angarano E., Basile M.R., Vincenti L.
Polyclinic of Bari ~ Bari ~ Italy
ROBOT-ASSISTED SPLEEN-PRESERVING DISTAL PANCREATECTOMY FOR MUCINOUS
CYSTADENOMA OF PANCREATIC NECK
Marano L., Listorti C., Mazza S., Bellochi R., Patriti A.
Institution: Division of Multidisciplinary Robotic Surgery, “San Matteo degli Infermi
Hospital”– ASL Umbria 2, 06049, Spoleto (PG), Italy
ROBOTIC LYMPHADENECTOMY DURING PANCREATODUODENECTOMY WITH FIRST
SUPERIOR MESENTERIC ARTERY DISSECTION
Memeo R.*[1], Pessaux P.[2]
[1]
Ospedale “F.Miulli” ~ Acquaviva delle Fonti ~ Italy, [2]NHC ~ Strasbourg ~ France
PORTAL VEIN RESECTION AND TYPE OF RECONSTRUCTION OF PORTO-MESENTERIC
TRUNK FOR RADICAL SURGICAL TREATMENT OF PANCREATIC ADENO-CARCINOMA.
SINGLE CENTRE EXPERIENCE
Gardini A.*, Labarba G., Morgagni P., Dacapito F., Cavaliere D., Avanzolini A., Framarini
M., Ercolani G.
General and mininvasive Surgery ~ FORLI ~ Italy
Discussants: G. Butturini, R. Girelli, P. Di Sebastiano, P. Ubiali
LUNCHTIME
Selected communications:
14.30 - 16.30 COLORECTAL CANCER AND PERITONEAL CARCINOMATOSIS
28
Chairmen: S. Bonilauri, A.L. Gaspari, S. Scabini
14.30 NEXT-GENERATION SEQUENCING FOR MIRNA PROFILING OF STOOL AND PLASMA SAMPLES OF PATIENTS WITH COLORECTAL CANCER OR PRECANCEROUS
LESIONS
Gallo G.*[1], Realis Luc A.[1], Tarallo S.[3], Cordero F.[2], Pardini B.[3], Vineis P.[4], Naccarati A.[3], Clerico G.[1], Trompetto M.[1]
[1]
Department of Colorectal Surgery - Clinica S.Rita ~ Vercelli ~ Italy, [2]Department of Computer Sciences, University of Torino ~ Torino ~ Italy, [3]Human Genetics Foundation ~ Torino ~ Italy, [4]School of Public Health, Imperial College of
London ~ London ~ United Kingdom
14.40 EARLY COLORECTAL CANCER: IS SURGERY ALWAYS MANDATORY?
Brighi M.*[1], De Siena N.[1], Vaccari S.[1], Pagano N.[2], Luppi G.[2], Cervellera M.[1],
Tonini V.[1]
TUESDAY, OCTOBER 25th 2016
Chirurgia d’Urgenza – Cervellera. Sant’Orsola-Malpighi. Università degli Studi
di Bologna. ~ Bologna ~ Italy, [2]Gastroenterologia - Bazzoli. Sant’Orsola-Malpighi. ~ Bologna ~ Italy
14.50 PURE NOTES TOTAL MESORECTAL EXCISION (TME) FOR PATIENTS WITH RECTAL
NEOPLASIA IS IT POSSIBLE TO GO ALL THE WAY UP FROM THE ANUS?
D’’Alessandro A.*, Canonico G., Chouillard E.
CHIPS ~ Poissy ~ France
15.00 TRANSCRIPTIONAL SIGNATURE OF PSEUDOMYXOMA PERITONEI: AN ENHANCEMENT OF TREATMENT STRATEGY AND OUTCOME PREDICTION
Vaira M.*, Robella M., Isella C., Borsano A., Mignone A., Medico E., De Simone M.
Candiolo Cancer Institute, FPO-IRCCS ~ Candiolo, Torino ~ Italy
15.10 REITERATED SURGICAL CYTOREDUCTION AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY IN PATIENTS AFFECTED BY PERITONEAL CARCINOSIS: A
MULTI-CENTRIC ITALIAN EXPERIENCE
Vaira M.[1], Robella M.[1], Londero A.P.[2], Bertozzi S.[3], Borsano A.[1], Santangelo
A.[3], Bacchetti S.[3], De Simone M.[1], Pasqual E.M.*[3]
[1]
Candiolo Cancer Institute, FPO - IRCCS, Unit of Surgical Oncology, Strada Prov.
142 Km 3.95, 10060 Candiolo - Torino ~ Candiolo ~ Italy, [2]UO Ginecologia ed
Ostetricia, Ospedale San Polo, AAS 2, 34074 Monfalcone (GO). ~ Monfalcone
~ Italy, [3]Advance Surgical Oncology Center, Clinic of Surgery, AOUD, Piazzale
Santa Maria Misericordia, 33100 Udine,Italy. ~ Udine ~ Italy
15.20 SINGLE-PORT PRESSURIZED INTRAPERITONEAL AEROSOL CHEMOTHERAPY
(PIPAC) ASSOCIATED WITH SYSTEMIC CHEMOTHERAPY: A SAFE AND PROMISING
STRATEGY FOR PERITONEAL CARCINOMATOSIS.
Robella M.*, Vaira M., Borsano A., De Simone M.
Candiolo Cancer Institute, FPO - IRCCS ~ Candiolo, Torino ~ Italy
15.30 MANAGEMENT OF MALIGNANT COLONIC POLYPS (T1). ENDOSCOPIC POLYPECTOMY VS SURGERY AND ANALYSIS OF PATHOLOGICAL RISK FACTORS FOR
LYMPH NODE METASTASIS: A PROSPECTIVE MONOCENTRIC STUDY
Parini D.*[1], Zuolo M.[1], Meggiato T.[2], Del Favero G.[2], Galeotti F.[1]
[1]
UOC Chirurgia generale, Ospedale Santa Maria della Misericordia ~ Rovigo ~
Italy, [2]SOC Gastroenterologia e Endoscopia Digestiva, Ospedale Santa Maria
della Misericordia ~ Rovigo ~ Italy
15.40 LAPAROSCOPIC TATME FOR MID-LOW RECTAL CANCER: SHORT- AND MIDTERM RESULTS
Mellano A.*, Muratore A., Marsanic P., Failla A.
Candiolo Cancer Institute -IRCCs ~ Candiolo, Turin ~ Italy
Discussants: G.L. Baiocchi (Bs) G. Garulli (Riccione), M. Martinotti (CR), A. Parisi (TR)
[1]
29
TUESDAY, OCTOBER 25th 2016 - 15.00
POSTER SESSION
1. POST-RADIOTHERAPY ATYPICAL VASCULAR LESIONS AND ANGIOSARCOMAS OF
THE BREAST: A COMMON MOLECULAR PATHWAY?
Calderoni* S.*, Cuoghi* M., Ferrarini* R., Asioli S., Morandi L., Brotto M., Corradini
A.G., Cucchi M.C., Foschini M.P.
Bologna ~ Bologna ~ Italy
2. FDG PET/CT AND BREAST CANCER: SURGERY OR NEOADJUVANT CT?
Invento A.*[1], Pellini F.[1], Mirandola S.[1], Grigolato D.[2], Ferdeghini M.[2], Pollini G.P.[1]
[1]
Breast Unit Verona USD Chirurgia Senologica ~ Verona ~ Italy, [2]UOC MEDICINA
NUCLEARE VERONA ~ VERONA ~ Italy
3. PROGNOSTIC VALUE OF THE MULTIPLE MICROMETASTASES IN THE SENTINEL
NODE OF BREAST CANCER ON AXILLARY LYMPH-NODE DISSECTION PROGNOSTIC
CONSIDERATION.
Calderoni* S.*, Cuoghi* M., Cucchi* M.C., Galluzzo* V., Monica M.T., Argazzi N.,
Asioli S., Foschini M.P.
Bologna ~ Bologna ~ Italy
4. RESECTION OF PRIMARY LEIOMYOSARCOMA OF THE INFERIOR VENA CAVA (IVC)
WITH RECONSTRUCTION: A CASE SERIES
Sandrucci S.*[1], Merlo M.[2], Grignani G.[3], Lista P.[4], Verri A.[2], Pau R.[2]
[1]
Visceral Sarcoma Unit, City of Health and Science University Hospital ~ Torino ~
Italy, [2]Vascular surgery department, City of Health and Science University Hospital ~
Torino ~ Italy, [3]Division of Medical Oncology, Candiolo Cancer Institute-FPO- IRCCS,
Candiolo ~ Torino ~ Italy, [4]Division of Medical Oncology, City of Health and Science
University Hospital ~ Torino ~ Italy
5. Robot-assisted anatomic liver resection of Sg3 for hepatocellular carcinoma
Listorti C., Marano L.,Spaziani A.,Bartoli A., Patriti A.
Institution: Division of Multidisciplinary Robotic Surgery, “San Matteo degli Infermi
Hospital”– ASL Umbria 2, 06049, Spoleto (PG), Italy
6. OESOPHAGECTOMY FOR CANCER: ANALYSES ON OUTCOMES AND INTENSIVE
CARE UNIT INVOLVEMENT
Puccetti F.*, Madonini M., De Pascale S., Balazova J., Lascari V., Fumagalli U.
IRCCS Humanitas Research Hospital ~ Rozzano (MI) ~ Italy
30
7. ROBOT-ASSISTED IVOR LEWIS ESOPHAGECTOMY
Pallabazzer G.*, Santi S., D’’Imporzano S., Solito B.
Esophageal Surgery Unit, Department of Surgery , Azienda Ospedaliero-Universitaria
Pisana ~ Pisa ~ Italy
8. CLINICOPATHOLOGIC CHARACTERISTICS AND PROGNOSTIC FACTORS OF GASTRIC
CANCER IN THE ELDERLY PATIENTS OVER 75 YEARS
Salandini M.C.*, Gasparini G., Orsenigo E., Carlucci M.
San Raffaele Hospital ~ Milan ~ Italy
POSTER
9. CLINICOPATHOLOGIC CHARACTERISTICS AND PROGNOSTIC FACTORS OF GASTRIC
CANCER IN YOUNG PATIENTS
Perali C.*, Orsenigo E., Salandini M.C., Carlucci M.
San Raffaele Hospital ~ Milan ~ Italy
10. FAST TRACK ITEMS COMPLIANCE IN ELDERLY GASTRIC CANCER PATIENTS:
PRELIMINAR ANALYSIS OF A SINGLE CENTRE SERIES
Ruspi L.*, Galli F., Peverelli C., Inversini D., Martignoni F., Di Rocco G., Boni L.,
Dionigi G., Rausei S.
Department of Surgery - University of Insubria ~ Varese ~ Italy
11. INDOCYANINE GREEN-ENHANCED FLUORESCENCE TO EVALUATE DUODENAL STUMP
PERFUSION DURING GASTRECTOMY
Ruspi L.*, Galli F., Pappalardo V., Lavazza M., Boni L., Dionigi G., Rausei S.
Department of Surgery - University of Insubria ~ Varese ~ Italy
12. D2 LYMPHADENECTOMY FOR GASTRIC CANCER
Lavazza M.*, Ruspi L., Galli F., Martignoni F., Di Rocco G., Boni L., Dionigi G., Rausei
S.
Department of Surgery - University of Insubria ~ Varese ~ Italy
13. DIAGNOSTIC VALUE OF EUS IN THE SELECTION OF PATIENTS WITH GASTRIC
CANCER ELIGIBLE FOR A NEOADJUVANT CHEMOTHERAPY
Marra D.*[1], Corradini G.[1], Antonini F.[2]
[1]
General Surgery ~ Fermo ~ Italy, [2]Gastroenterology ~ Fermo ~ Italy
14. SECOND LEVEL LYMPHADENECTOMY IN GASTRIC CANCER: IS THE NUMBER OF
RETRIEVED NODES CRUCIAL?
Galli F.*, Ruspi L., Inversini D., Martignoni F., Di Rocco G., Dionigi G., Rausei S.
Department of Surgery, University of Insubria ~ Varese ~ Italy
15. GASTRIC AND DUODENAL GIST: EMERGENCY AND ELECTIVE SURGERY
Alberici L.*, Luppi G., De Siena N., Brighi M., Cervellera M., Tonini V.
Chirurgia d’Urgenza - Cervellera. Sant’Orsola-Malpighi. Università degli Studi di
Bologna. ~ Bologna ~ Italy
16. SURGICAL OUTCOME OF LOCALLY ADVANCED ADENOCARCINOMAS OF THE
STOMACH AND GASTROESOPHAGEAL JUNCTION TREATED BY NEOADJUVANT
CHEMORADIATION.
Belluco C.*, Marco F., Olivieri M., Buonadonna A., Cannizzaro R., De Paoli A., Perin
T., Fornasarig M., Canzonieri V., Bertola G.
CRO – IRCCS, National Cancer Institute ~ Aviano ~ Italy
17. RADICAL SURGERY FOR GASTRIC CANCER IN OCTOGENARIAN PATIENTS
Casella F.*[1], Sansonetti A.[1], Necozione S.[2], Cofini V.[2], Capodacqua A.[2], Verzaro R.[1]
[1]
GENERAL SURGERY PROGRAM, M.G. VANNINI HOSPITAL ~ ROME ~ Italy, [2]MD
DEPARTMENT OF LIFE, HEALTH AND ENVIROMENTAL SCIENCES ~ L’AQUILA ~ Italy
31
POSTER
18. PRELIMINARY RESULTS OF ERAS PROTOCOL FOR GASTRIC CANCER
Casella F.*, Sansonetti A., Ferroni A., Rago T., Mattia S., Verzaro R.
GENERAL SURGERY PROGRAM, M.G. VANNINI HOSPITAL ~ ROME ~ Italy
19. SERUM CD26 LEVELS IN PATIENTS WITH GASTRIC CANCER: A NOVEL POTENTIAL
DIAGNOSTIC MARKER
Marano L.*[1], Listorti C.[1], De Luca R.[2], Di Martino N.[3], Patriti A.[1]
[1]
Robotic Surgery Unit - “San Matteo degli Infermi” Hospital - AUSL Umbria 2 Spoleto (PG) ~ Spoleto (PG) ~ Italy, [2]Department of Surgical Oncology, National
Cancer Research Centre - Istituto Tumori “G. Paolo II” ~ Bari ~ Italy, [3]second
university of naples ~ Naples ~ Italy
20. ANALYSIS OF SAFETY AND EFFICACY OF LAPAROSCOPIC RESECTION FOR
GASTROINTESTINAL STROMAL TUMOURS OF THE STOMACH AND LITTLE BOWEL
Scagliarini L.*, Anania G., Fabbri N., Giaccari S., Resta G.
Azienda ospedaliera universitaria di Ferrara ~ Ferrara ~ Italy
21. OVERALL AND DISEASE-FREE SURVIVAL IN PATIENTS TREATED WITH HIPEC FOR
ADVANCED GASTRIC CANCER WITH PERITONEAL CARCINOMATOSIS.
Montori G.*[1], Fugazzola P.[1], Coccolini F.[1], Ceresoli M.[1], Ansaloni L.[1]
[1]
Ospedale Papa Giovanni 23 ~ Bergamo ~ Italy
22. ROLE OF VOLUNTEERING FOR IMPROVING QUALITY AND PERFORMANCE IN
MANAGED GASTRIC CANCER
Vannelli A.*[1], Putortì A.[1], Rossi F.[1], Scolaro R.[2], Zanardo M.[1]
[1]
Division of Surgical Oncology Valduce Hospital ~ Como ~ Italy, [2]Division General
Surgery Policlinico G Martino ~ Messina ~ Italy
23. EX VIVO LYMPHADENECTOMY DURING GASTRIC SURGERY FOR ADENOCARCINOMA:
RESULT FROM A SINGLE CENTRE
Graziosi L.*, Marino E., Donini A.
general and Emergency Surgery, Santa Maria della Misericordia Hospital of Perugia
~ Perugia ~ Italy
32
24. EXTENDED INTERVAL AFTER NEOADJUVANT CHEMORADIOTHERAPY IN LOCALLY
ADVANCED RECTAL CANCER: A SINGLE CENTRE EXPERIENCE
Turati L.*[1], Steccanella F.[1], Russo A.A.[1], Petrelli F.[2], Rampulla V.[1], Bianco F.[1],
Barni S.[2], Sgroi G.[1]
[1]
Surgical Oncology Unit - Treviglio Hospital ~ Treviglio (BG) ~ Italy,
[2]
Clinical Oncology Unit - Treviglio Hospital ~ Treviglio (BG) ~ Italy
25. NODAL STAGING IN COLORECTAL CANCER: COMPARISON BETWEEN EMERGENCY
AND ELECTIVE SURGERY
Gasparini G.*, Luperto M., Orsenigo E., Carlucci M.
San Raffaele Hospital ~ Milano ~ Italy
POSTER
26. LAPAROSCOPIC TATME AND COLO-ANAL ANASTOMOSIS FOR RECTAL CANCER IN
AN OBESE PATIENT
Mellano A.*, Muratore A., Marsanic P., Failla A.
Candiolo Cancer Institute -IRCCs ~ Candiolo, Turin ~ Italy
27. TREATMENT OF A LATE RECTAL STUMP INSUFFICIENCY AFTER HARTMANN’S
PROCEDURE WITH THE VACUUM ASSISTED CLOSURE SYSTEM: IS IT WORTH?
Sandrucci S.*, Mobiglia A., Verra M., Esposito L.
Visceral Sarcoma Unit, University of Turin ~ torino ~ Italy
28. EFFECTIVENESS OF A BRIEF RISK SCREENING TOOL IN DETECTING FRAILTY IN ELDERLY
PATIENTS UNDERGOING EMERGENCY ABDOMINAL SURGERY. A PILOT STUDY.
Zattoni D.*[2], Cervellera M.[2], Calogero P.[1], Galetti F.[1], Garutti A.[1], Bacchi Reggiani
M.L.[3], Tonini V.[2]
[1]
Geriatrics Policlinico S.Orsola-Malpighi ~ Bologna ~ Italy, [2]General Surgery Policlinico S. Orsola-Malpighi ~ Bologna ~ Italy, [3]Statistics - Policlinico S. OrsolaMalpighi ~ Bologna ~ Italy
29. TRANSANAL NOTES TOTAL MESORECTAL EXCISION (TME) IN PATIENTS WITH
RECTAL CANCER: IS ANATOMY BETTER PRESERVED?
Canonico G.*, D’’Alessandro A., Chouillard E.
CHIPS ~ Poissy ~ France
30. PLACEMENT OF SELF-EXPANDABLE METAL STENTS AS A BRIDGE TO SURGERY:
IMPACT ON POST-OPERATIVE OUTCOME
Vaccari S.*, Cervellera M., Pirrera B., Alberici L., Brighi M., Belinga Atangana A.G.,
Picariello E., Tonini V.
Chirurgia d’Urgenza - Cervellera. Sant’Orsola-Malpighi. Università degli Studi di
Bologna. ~ Bologna ~ Italy
31. MULTIMODALITY APPROACH TO THE EXTRAPERITONEAL RECTAL CANCER
Pulighe F.*[1], Panagiotis P.[2], Scognamillo F.[2], Marrosu A.[2], Argenio G.[1], Balestra
F.[1], De Nisco A.[1], Guerra F.[1], Attene F.[2], Cruccu A.[1]
[1]
San Francesco Hospital of Nuoro ~ Nuoro ~ Italy, [2]Department of Surgical
Microsurgical and Medical Sciences, University of Sassari, V.le San Pietro 43B,
07100, Sassari ~ Sassari ~ Italy
32. TRANSANAL TOTAL MESORECTAL EXCISION (TATME): SURGICAL TECHNIQUE
DESCRIPTION
Persiani R.*, Biondi A., Santullo F., Pennestrì F., Tirelli F., Sicoli F., Lirosi M.C., Fico
V., D’’Ugo D.
Catholic University of Sacred Heart ~ Rome ~ Italy
33
POSTER
33. INTRACORPOREAL ANASTOMOSIS AFTER LAPAROSCOPIC RIGHT COLECTOMY.
GUILTY OR NOT GUILTY? A SYSTEMATIC REVIEW WITH METANALYSIS OF
LITERATURE.
Manigrasso M.*, Di Lauro K., Milone M.
University of Naples “Federico II” ~ Naples ~ Italy
34. NEOPLASTIC INTUSSUSCEPTION: A RARE CAUSE OF SMALL BOWEL OBSTRUCTION
Casati A.*, De Siena N., Alberici L., Pirrera B., Cervellera M., Tonini V.
Chirurgia d’Urgenza - Cervellera. Sant’Orsola-Malpighi. Università degli Studi di
Bologna. ~ Bologna ~ Italy
35. RESPONSE TO NEOADJUVANT CRT FOR DISTAL RECTAL CANCER: OUR EXPERIENCE
Sorbo G.*, Pirrera B., Vaccari S., De Siena N., Luppi G., Cervellera M., Tonini V.
Chirurgia d’Urgenza - Cervellera. Sant’Orsola-Malpighi. Università degli Studi di
Bologna. ~ Bologna ~ Italy
36. ROBOTIC TOTAL MESORECTAL EXCISION WITH DAVINCI XI SYSTEM
Misitano P.*, Formisano G., Giuliani G., Krizzuk D., De Luca M., Salvischiani L.,
Bianchi P.P.
MISERICORDIA HOSPITAL ~ GROSSETO ~ Italy
37. ROBOTIC RIGHT COLECTOMY WITH COMPLETE MESOCOLIC EXCISION PERFORMED
BY A NOVICE SURGEON
Giuliani G.*, Formisano G., Misitano P., Coratti F., De Luca M., Krizzuk D.,
Salvischiani L., Bianchi P.P.
MISERICORDIA HOSPITAL ~ Grosseto ~ Italy
38. ELEVATED PLATELET COUNT IS A NEGATIVE PREDICTIVE FACTOR FOR
PATHOLOGICAL TUMOR RESPONSE AND LONG-TERM ONCOLOGIC OUTCOME
IN LOCALLY ADVANCED RECTAL CANCER UNDERGOING PREOPERATIVE
CHEMORADIATION
Forlin M.*[1], Rega D.[2], Olivieri M.[1], Bertola G.[1], Buonadonna A.[1], Cannizzaro R.[1],
Canzonieri V.[1], De Paoli A.[1], Pace U.[2], Scala D.[2], Del Rio P.[2], Belluco C.[1]
[1]
CRO – IRCCS, National Cancer Institute ~ Aviano ~ Italy, [2]Fondazione G.Pascale IRCCS ~ Napoli ~ Italy
34
39. CARCINOMA OF THE SPLENIC FLEXURE: WHAT SURGICAL TREATMENT.
Rega D.*, Pace U., Scala D., Ruffolo F., Sassaroli C., Delrio P.
Colorectal Surgical Oncology - istituto nazionale per lo studio e la cura dei tumori
“Fondazione Giovanni Pascale” IRCCS ~ Napoli ~ Italy
40. RECENT ADVANCES IN NEOADJUVANT THERAPY FOR RECTAL CANCER
Panier Suffat L.*, Piva C., Sciacero P., Bombaci S., Scapino B., Bertotti L., Barengo
E., Rosato L.
Giorgio Vellani S.C.O. Oncologia.
ASL TO 4 ~ Ivrea ~ Italia
POSTER
41. RECTAL CANCER IN URGENCY, WHAT’S THE STRATEGY?
Panier Suffat L.*, Bertotti L., Piva C., Sciacero P., Scapino B., Contratto R., Rosato L.
Giorgio Vellani S.C.O. Oncologia.
ASL TO 4 ~ Ivrea ~ Italia
42. TREATMENT OF COLORECTAL CANCER: MULTIDISCIPLINAY APPROACH
Scagliarini L., Anania G., Marino S.*, Marchitelli I., Resta G.
Azienda ospedaliera universitaria di Ferrara ~ Ferrara ~ Italy
43. TOTALLY LAPAROSCOPIC RIGHT COLECTOMY WITH COMPLETE MESOCOLON
EXCISION
Lucchi A.*, Berti P., Gabbianelli C., Alagna V., Guerra M., Corbucci Vitolo G., Vandi F.,
Garulli G.
AUSL della Romagna ~ Riccione ~ Italy
44. LAPAROSCOPIC RIGHT HEMICOLECTOMY WITH INTRACORPOREAL ANASTOMOSIS.
HOW DO I DO IT
Simonelli V.*, Rijkaerts M.
Centre Hospitalier de Nivelles ~ Nivelles ~ Belgium
45. DOES PATHOLOGIC RESPONSE TO NEOADJUVANT CHEMORADIATION IN RECTAL
CANCER INFLUENCE EARLY SURGICAL OUTCOME? THE “G. PAOLO II” CANCER
RESEARCH CENTRE EXPERIENCE.
De Luca R.[1], Caliandro C.[1], Ruggieri E.[1], Lomonaco R.[1], Rucci A.[1], Ammendola
M.*[2], Nardone A.[1], Simone M.[1]
[1]
National Cancer Research Centre “G.Paolo II” Istituto Tumori ~ BARI ~ Italy, [2]
Clinical Surgery Unit.University of “Magna Grecia” ~ Catanzaro ~ Italy
46. SIDE-TO-SIDE STAPLED COLORECTAL ANASTOMOSIS IN LEFT LAPAROSCOPIC
COLECTOMY: EXPERIENCE IN A SINGLE CENTER
Gennai A.*, Muzio E., Dova L., Francone E., Feleppa C., Bianchi C., Falco E., Berti S.
Ospedale S.Andrea ASL 5 ~ La Spezia ~ Italy
47. PROGNOSTIC VALUE OF PERITONEAL CARCINOEMBRYONIC ANTIGEN IN PERITONEAL
LAVAGE IN PATIENTS AFFECTED BY COLON CANCER
Graziosi L., Marino E., Bartolini V.*, Donini A.
general and Emergency Surgery, Santa Maria della Misericordia Hospital of Perugia
~ Perugia ~ Italy
48. RESECTABILITY AFTER NEOADJUVANT THERAPY FOR PRIMARY UNRESECTABLE
PANCREATIC ADENOCARCINOMA
Beltrame V.*[1], Gruppo M.[1], Patanè G.[1], Paladina I.[2], Crivellari G.[2], Valmasoni M.[1],
Spolverato Y.C.[1], Pozza G.[1], Sperti C.[1]
[1]
Department of Surgery, Oncology and Gastroenterology, 3rd Surgical Clinic,
University of Padua ~ Padova ~ Italy, [2]Veneto Institute of Oncology (IOV) ~ Padova
~ Italy
35
POSTER
49. IRREVERSIBLE ELECTROPORATION AS TREATMENT OF LOCALLY ADVANCED
AND AS COMPLEMENT OF SURGERY IN BORDERLINE RESECTABLE PANCREATIC
ADENOCARCINOMA
Marsanic P.*, Mellano A., Sottile A., De Simone M.
IRCCs ~ Candiolo ~ Italy
50. SURGICAL AND PATHOLOGICAL OUTCOME AFTER DOWNSTAGING IN PANCREATIC
CANCER INTRODUCTION
Frigerio I.*[1], Pulvirenti A.[2], Giardino A.[1], Paolo R.[1], Girelli R.[1], Scopelliti F.[1],
Butturini G.[1]
[1]
Casa di Cura Pederzoli ~ Peschiera del Garda ~ Italy, [2]Pancreas Institute ~ Verona
University, Verona ~ Italy
51. SELECTING PATIENTS FOR SURGERY AFTER PRIMARY CHEMOTHERAPY FOR NONMETASTATIC PANCREATIC ADENOCARCINOMA
Nobile S.*, Reni M., Zanon S., Nicoletti R., Andreasi V., Castoldi R., Partelli S., Crippa
S., Falconi M., Balzano G.
San Raffele Scientific Institute ~ Milan ~ Italy
52. PORTAL VEIN RECOSTRUCTION DURING WHIPPLE PROCEDURE
D’’Angelo F., Sirimarco D.*, Antolino L., Aurello P., Petrucciani N., Valabrega S.,
Kazemi Nava A., Nigri G., Ramacciato G.
Sapienza Università di Roma - Azienda Ospedaliera Sant’Andrea ~ Roma ~ Italy
53. NEOADJUVANT PROTOCOLS IN RESECTABLE, BORDERLINE RESECTABLE AND
LOCALLY ADVANCED PANCREATIC CANCER: WHERE ARE WE NOW?
Antolino L.*, Kazemi Nava A., Sirimarco D., De Siena M., Aurello P., Ramacciato G.,
D’’Angelo F.
Università Sapienza, Facoltà di Medicina e Psicologia, Dipartimento di Scienze
Medico-Chirurgiche e Medicina Traslazionale ~ Roma ~ Italy
36
54. PARIETAL CELL GASTRIC CARCINOMA – AN EXTREMELY RARE ENTITY. TWO NEW
CASES WITH FIRST-TIME ASSESSMENT AND RECORDING OF ABSENCE OF HER2
EXPRESSION AND LITERATURE REVIEW
V. Mavroeidis1, M. Demonakou2, K. Kandilaris2, Z. Almpanis2, K. Alexiou1, D.
Matthioudakis1, F. Menikou3, N. Economou1
1st Surgical Department, Sismanogleio General Hospital, Athens, Greece
Department of Pathology, Sismanogleio General Hospital, Athens, Greece
2nd Surgical Department, Sismanogleio General Hospital, Athens, Greece
55. STRATEGIA TERAPEUTICA E RISULTATI NEL CARCINOMA COLECISTICO INCIDENTALE
Frena A.*[1], Patauner S.[2], Fissneider B.[2], Martin F.[2]
[1]
Chirurgia Epatobiliare ~ Bolzano ~ Italy, [2]Chirurgia Generale ~ Bolzano ~ Italy
POSTER
56. EFFECT OF NEOADJUVANT CHEMOTHERAPY IN PATIENTS SUBMITTED TO LIVER
RESECTION FOR COLORECTAL LIVER METASTASES.
Bianchi G.*, Lamecchi L., Iaria M., Dalla Valle R.
Chirurgia generale e dei trapianti d’organo ~ Parma ~ Italy
57. MINIMALLY INVASIVE (MI) VS OPEN PARENCHYMAL-PRESERVING LIVER RESECTIONS
IN THE SEGMENTS (SG) 7 AND 8.
Listorti C.*[1], Mazza S.[1], Bartoli A.[2], Bellochi R.[2], Spaziani A.[2], Marano L.[2], Patriti
A.[2]
[1]
Università di Perugia ~ Perugia ~ Italy, [2]Division of Robotic Surgery, Department
of Surgery. ASL Umbria 2. San Matteo degli Infermi Hospital, Spoleto. Italy ~ Spoleto
~ Italy
58. MAJOR HEPATECTOMY FOR COLORECTAL LIVER METASTASES IN PATIENTS AGED
OVER 80: A PROPENSITY SCORE MATCHING ANALYSIS
Memeo R.*[1], French Surgical Association (.F.D.C.[2]
[1]
Ospedale “F.Miulli” ~ Acquaviva delle Fonti ~ Italy, [2]French Surgical Association
(Association Française de Chirurgie) ~ France ~ France
59. MARGIN STATUS IS STILL AN IMPORTANT PROGNOSTIC FACTOR IN HEPATECTOMIES
FOR COLORECTAL LIVER METASTASES: A PROPENSITY SCORE MATCHING ANALYSIS
Memeo R.*[1], French Surgical Association (.F.D.C.[2]
[1]
Ospedale “F.Miulli” ~ Acquaviva delle Fonti ~ Italy, [2]French Surgical Association
(Association Française de Chirurgie) ~ France ~ France
60. LAPAROSCOPIC RIGHT HEPATECTOMY AFTER TACE AND PVE FOR HCC
Memeo R.*[1], Pessaux P.[2]
[1]
Ospedale “F.Miulli” ~ Acquaviva delle Fonti ~ Italy, [2]NHC ~ Strasbourg ~ France
61. LAPAROSCOPIC RIGHT HEPATECTOMY FOR COLORECTAL METASTASES
Giuliante F.*, Ardito F., Coppola A., Panettieri E.
Catholic University, Hepatobiliary Surgery Unit ~ Rome ~ Italy
62. INFLAMMATORY MARKERS AS PROGNOSTIC FACTORS OF SURVIVAL IN TACE
PATIENTS
Rebonato A.*[1], Maiettini D.[1], Graziosi L.[2], Marino E.[2], Donini A.[2]
[1]
Radiology Section of University of Perugia ~ Perugia ~ Italy, [2]General and
Emergency Surgery, Santa Maria della Misericordia Hospital of Perugia ~ Perugia ~
Italy
37
POSTER
63. A CASE OF STERNAL CHONDROSARCOMA: SOFT TISSUE, AND SKELETAL
DIAFRAGMATIC DEFECT RECONSTRUCTION WITH A DOUBLE POLYPROPYLENE /
EPTFE PROSTHESIS
Sandrucci S.*[1], Bruna M.C.[2], Mossetti C.[2]
[1]
Visceral sarcoma Unit, City of Health and Science University Hospital ~ Torino ~
Italy, [2]Thoracic Surgery Department, city of Health and Science University Hospital ~
Torino ~ Italy
64. SYNCHRONOUS PRESENTATION OF CANCER IN THE LACRIMAL AND SALIVARY
GLANDS – ONCOLOGICAL ASPECTS
V. Mavroeidis1, P. Chatzimpaloglou2, F. Menikou3, F. Saffioti4
1stSurgical Department, Sismanogleio General Hospital, Athens, Greece
Ophthalmologist, Athens, Greece
2nd Surgical Department, Sismanogleio General Hospital, Athens, Greece Department
of Clinical and Experimental Medicine, University Hospital of Messina, Messina, Italy
65. INTRAOPERATIVE ADHESIONS DEVELOPING DURING CLOSED-ABDOMEN HIPEC
Lotti M.*, Giulii Capponi M., Ansaloni L., Frigerio L.
Ospedale Papa Giovanni XXIII ~ Bergamo ~ Italy
66. NEOADJUVANT CHEMOTHERAPY-RELATED LEUKOPOENIA AS A BIOMARKERS
PREDICTING SURVIVAL OUTCOMES IN LOCALLY ADVANCED CERVICAL CANCER
Bogani G.*, Ditto A., Martinelli F., Signorelli M., Raspagliesi F., Lorusso D.
National Cancer Institute ~ Milan ~ Italy
67. TRANSANAL TOTAL MESORECTAL EXCISION AFTER NEOADJUVANT THERAPY FOR
RECTAL CANCER: PRELIMINARY SHORT-TERM ONCOLOGICAL RESULTS.
Cossu A.*, Elmore U., Vignali A., De Nardi P., Maggi G., Lemma M., Parise P., Rosati R.
Department of Gastrointestinal Surgery, San Raffaele Scientific Institute, University
Vita Salute ~ Milano ~ Italy
68. MINIMALLY INVASIVE SURGICAL APPROACH FOR RADICALIZATION OF INCIDENTAL
GALLBLADDER NEOPLASM: SAFETY, FEASIBILITY AND SHORT TERM OUTCOMES
Garritano S.*[1], Spampinato M.G.[2]
[1]
Policlinico Umberto I ~ Roma ~ Italy, [2]Policlinico Abano Terme ~ Abano Terme ~
Italy
38
69. LAPAROSCOPIC LIVER RESECTIONS: A SINGLE CENTRE EXPERIENCE
Bizzoca C.*, Maselli E., Vincenti L.
Polyclinic Hospital ~ Bari ~ Italy
70. LAPAROSCOPIC HARTMANN’S PROCEDURE ASSOCIATED WITH RIGHT
NEPHRECTOMY IN A 78 YEAR- OLD MAN WITH SYNCHRONOUS RECTAL CARCINOMA
AND PAPILLARY RENAL CANCER.
Gennai A.*, Muzio E., Francone E., Falco E., Feleppa C., Berti S.
POLL 5 ~ La Spezia ~ Italy
POSTER
71. VOLUMINOUS JEJUNUM’S SARCOMAOTID CARCINOMA: LAPAROSCOPIC RESECTION
OF LOCALLY ADVANCED MISSING PRIMITIVE LESION.
Gennai A.*, Muzio E., Dova L., Francone E., Feleppa C., Bianchi C., Falco E., Berti
S.S.Andrea Hospital POLL-ASL5 ~ La Spezia ~ Italy
72. FEASIBILITY AND SAFETY OF ROBOTIC COLORECTAL CANCER SURGERY IN
ELDERLIES: A MATCHED CASE-CONTROL STUDY FROM A SINGLE CENTER
Graziosi L., Marino E.*, Zavagno V., Bartolini V., Donini A.
General and Emergency Surgery, Santa Maria della Misericordia Hospital of Perugia
~ Perugia ~ Italy
39
GENERAL INFORMATION
CONFERENCE VENUE
Hotel Giò Wine e Jazz Area a Perugia
Via R. D’Andreotto, 19
06124 Perugia (PG)
Tel. 39 075 5731100
[email protected]
The Hotel is in the city centre of Perugia, 1 km far away from the railway station, and 200 mt
from the minimetrò station. You reach the historic centre in 5 minutes by minimetrò. From
Hotel Giò you can reach the historic centre in 5 minutes by car or in 20 minutes on foot.
SICO SECRETARIAT and ORGANIZING SECRETARIAT
Two distinct secretariats will be at the disposal of the conference participants.
The Organizing Secretariat will be at the disposal of the conference participants at Giò
Hotel starting from 10.00 am of 23 October 2016 and over the following days until the
end of the conference. The SICO Secretariat is at the disposal of MEMBERS to answer
any enquiry for societal information, to check and settle their membership fee; it will also
be available to accept new memberships.
Registration with the 2nd International Conference of Surgical Oncology is mandatory
and will entitle to: attend the scientific sessions of 23/24/25 October, receive a conference set, pocket lunch and coffee breaks as planned, attendance certificate
OVER-40 SICO MEMBERS
(up to date with the payment of the 2016 membership fee € 100.00) *
Free of charge
UNDER-40 SICO SPECIALIZING MEMBERS
(up to date with the payment of the 2016 membership fee € 50.00) *
Free of charge
GIRCS MEMBERS
(up to date with the payment of the 2016 membership fee)
NON-SICO MEMBERS
Free of charge
Specializing medicine doctor **
Medicine Student***
40
€ 250.00
Free of charge
Free of charge
Membership fees, including 22% VAT
NOTES:
*The 2nd International Conference of Surgical Oncology is free of charge for SICO MEMBERS up to date with the
payment of the 2016 membership fee. However, they will still have to send the Conference registration form to
register. To become members please visit the website www.sicoonline.org.
** Specializing medicine doctors whose work will be selected for submission at the plenary session are required to become members (€ 50.00);
***Please send the certificate of enrolment with your University Course
CANCELLATION POLICY: The membership fee may only be reimbursed if cancellation is notified to the Organizing Secretariat not later than 15 JULY 2016.
GENERAL INFORMATION
SICO Members Meeting
The SICO Members Meeting will be held on Monday the 24th of October at the Town Hall
of Giò Hotel from 6.30 pm to 7.30 pm
PRESENTERS
At least two of the Presenters of the selected communications (as either oral presentations or posters) should be members of the Italian Society of Oncological Surgery and up
to date with the payment of the 2016 membership fee.
SCIENTIFIC INFORMATION
The Congress will include parallel sessions.
SHOWINGS
Only the showing of Personal Computer images is accepted: traditional slide projectors
will not be installed and the use of personal PCs is not allowed. The rooms are equipped
with a video-projector connected to a Personal Computer for the presentation of the
works. The relevant files shall be prepared on Power Point 2000 and delivered at least 2
hours before the beginning of the session on a pen drive to the computer centre.
The computer centre will be network connected to the conference rooms: all the screenings will be automatically forwarded to the right room.
GUIDELINES FOR CHAIRMEN AND SPEAKERS
Chairmen shall:
- be in the room at least 10 minutes before the beginning of the session;
- make sure that the session and the presentations remain within the allotted times;
Speakers shall:
- identify the room where the session is held in due time;
- hand in the visuals of their presentation, if possible, at least 2 hours before the beginning of the session to the computer centre
- be in the room at least 10 minutes before the beginning of the session.
CME CREDITS
The event of 24/25 October will receive single accreditation from the Ministry of Health
for the following professions:
Medicine Doctors-Surgeons reference subjects: general surgery; gastroenterology; internal medicine; oncology; radiotherapy; obstetrics and gynaecology; radiodiagnostics;
nurses; Biologists and TSRM.
An attendance sheet will be signed when entering and leaving the room and credits will
only be certified if the attendance time will be the actual set time for the event and if the
final test to check the learning level will be passed.
41
GENERAL INFORMATION
The CME credit certification will be sent by e-mail after completing the set procedures.
The CME Provider is Kassiopea Group, recognized by AGENAS under number 305. Attendance certificates
At the end of the Conference all duly registered attendants will receive an attendance
certificate. Certificates will only be given at the end of the sessions, also in case of late
closing
Badges
Admission to the conference venue, the exhibition area and the scientific sessions will
only be possible if in possession of the bar-code badge given by the Organizing Secretariat at the time of registration.
The badge is a personal document and shall be shown to the controlling staff. It is the
only valid document to collect the attendance certificate and the only way to receive
credits.
Amendments
The Scientific Secretariat and the Organizing Secretariat reserve the right to make all the
necessary amendments to the programme which are deemed necessary for technical
and/or scientific reasons.
42
SPONSORS
PLATINUM SPONSOR
GOLD SPONSOR
SILVER SPONSOR
43
SOCIETÀ ITALIANA DI CHIRURGIA ONCOLOGICA
Italian Society of Surgical Oncology, ESSO affiliated
ORGANIZING SECRETARIAT and NATIONAL SECRETARIAT SICO
Via Stamira 10
09123 Cagliari
Tel. 070651242 Fax 070656263
[email protected]
www.sicoonline.org
www.kassiopeagroup.com